Organigram Sets Cannabis Supply Deal in the UK

It expects to supply 1,700 kilograms of indoor-grown dried cannabis flower to Avida Medical.

I Stock 483300738
iStock/tvirbickis

Organigram, a leading licensed producer of cannabis, announced its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business.

Subject to the terms of the Agreement, the company expects to supply 1,700 kilograms of indoor-grown dried cannabis flower to Avida Medical in the UK over a period of three years.

"We are pleased to partner with Avida Medical in the UK, marking yet another exciting milestone for Organigram's expansion into the global market. As frontrunners in the cannabis industry, we recognize the immense potential of the UK market. Our decision to further expand into this market stems from our commitment to ensuring patients have access to reliable, high-quality medical cannabis offerings,โ€ said Tim Emberg, Chief Commercial Officer of Organigram. โ€œWith our extensive industry expertise in cultivation and production, we are poised to elevate accessibility and cater to the evolving requirements of patients in the UK. We are confident that this strategic move will not only strengthen our international presence but also reinforces our objective of advancing global access to medical cannabis,โ€ Emberg concluded.

โ€œOur agreement with Organigram exemplifies our commitment to providing the highest quality medicine and service to patients. The UK is home to one of the largest patient populations using medicinal cannabis in Europe, and this is set to grow exponentially over the next four years. As the market matures, it is those producers and manufacturers that have focused on ensuring the highest quality of their products and processes, that will determine the companies that succeed,โ€ commented Paul Parkinson, Chief Executive Officer, Avida Medical.

โ€œThis is a hugely positive collaboration for Avida Medical and brings us a step closer to becoming one of the pre-eminent manufacturers of medicinal cannabis products here in the UK,โ€ he added.

More in Distribution